These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 18198424)
21. Key Peptides and Proteins in Alzheimer's Disease. Penke B; Bogár F; Paragi G; Gera J; Fülöp L Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056 [TBL] [Abstract][Full Text] [Related]
22. Activation of caspase-6 in aging and mild cognitive impairment. Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160 [TBL] [Abstract][Full Text] [Related]
23. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease. Knezovic A; Osmanovic-Barilar J; Curlin M; Hof PR; Simic G; Riederer P; Salkovic-Petrisic M J Neural Transm (Vienna); 2015 Apr; 122(4):577-92. PubMed ID: 25808906 [TBL] [Abstract][Full Text] [Related]
24. Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ. Miners JS; Clarke P; Love S Brain Pathol; 2017 May; 27(3):305-313. PubMed ID: 27248362 [TBL] [Abstract][Full Text] [Related]
26. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model. Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551 [TBL] [Abstract][Full Text] [Related]
27. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β. Tayler H; Fraser T; Miners JS; Kehoe PG; Love S J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272 [TBL] [Abstract][Full Text] [Related]
28. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities. Tran HT; LaFerla FM; Holtzman DM; Brody DL J Neurosci; 2011 Jun; 31(26):9513-25. PubMed ID: 21715616 [TBL] [Abstract][Full Text] [Related]
29. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. Cohen AD; Price JC; Weissfeld LA; James J; Rosario BL; Bi W; Nebes RD; Saxton JA; Snitz BE; Aizenstein HA; Wolk DA; Dekosky ST; Mathis CA; Klunk WE J Neurosci; 2009 Nov; 29(47):14770-8. PubMed ID: 19940172 [TBL] [Abstract][Full Text] [Related]
30. Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects. Maccioni RB; Lavados M; Guillón M; Mujica C; Bosch R; Farías G; Fuentes P Neurobiol Aging; 2006 Feb; 27(2):237-44. PubMed ID: 16399209 [TBL] [Abstract][Full Text] [Related]
31. Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease. Shinohara M; Koga S; Konno T; Nix J; Shinohara M; Aoki N; Das P; Parisi JE; Petersen RC; Rosenberry TL; Dickson DW; Bu G Brain; 2017 Dec; 140(12):3301-3316. PubMed ID: 29161341 [TBL] [Abstract][Full Text] [Related]
32. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. Näslund J; Haroutunian V; Mohs R; Davis KL; Davies P; Greengard P; Buxbaum JD JAMA; 2000 Mar 22-29; 283(12):1571-7. PubMed ID: 10735393 [TBL] [Abstract][Full Text] [Related]
33. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease. Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603 [TBL] [Abstract][Full Text] [Related]
34. Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain. Horie K; Barthélemy NR; Mallipeddi N; Li Y; Franklin EE; Perrin RJ; Bateman RJ; Sato C Acta Neuropathol Commun; 2020 Aug; 8(1):149. PubMed ID: 32854776 [TBL] [Abstract][Full Text] [Related]
35. Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. Steinerman JR; Irizarry M; Scarmeas N; Raju S; Brandt J; Albert M; Blacker D; Hyman B; Stern Y Arch Neurol; 2008 Jul; 65(7):906-12. PubMed ID: 18625856 [TBL] [Abstract][Full Text] [Related]
36. Association of APOE with tau-tangle pathology with and without β-amyloid. Farfel JM; Yu L; De Jager PL; Schneider JA; Bennett DA Neurobiol Aging; 2016 Jan; 37():19-25. PubMed ID: 26481403 [TBL] [Abstract][Full Text] [Related]
37. Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Vemuri P; Wiste HJ; Weigand SD; Knopman DS; Shaw LM; Trojanowski JQ; Aisen PS; Weiner M; Petersen RC; Jack CR; Ann Neurol; 2010 Mar; 67(3):308-16. PubMed ID: 20373342 [TBL] [Abstract][Full Text] [Related]
38. Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunction. Yu CH; Song GS; Yhee JY; Kim JH; Im KS; Nho WG; Lee JH; Sur JH J Comp Pathol; 2011 Jul; 145(1):45-58. PubMed ID: 21256508 [TBL] [Abstract][Full Text] [Related]
39. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488 [TBL] [Abstract][Full Text] [Related]
40. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein. Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]